Amgen Inc. (AMGN) Buys Avidia
Amgen Inc. said Friday it will buy Avidia, a Mountain View drug company with a drug candidate for autoimmune disease in Phase I trials, for $290 million in cash.
Thousand Oaks-based Amgen (NASDAQ: AMGN - News) has facilities in both Fremont and South San Francisco. It has about 370 workers in Fremont and about 600 in South San Francisco.
The boards of both companies have approved the deal, which should close in the fourth quarter of 2006. Avidia will be a wholly owned subsidiary of Amgen.
Published September 29, 2006 by San Francisco Business Times
Source: BizJournals.com
Thousand Oaks-based Amgen (NASDAQ: AMGN - News) has facilities in both Fremont and South San Francisco. It has about 370 workers in Fremont and about 600 in South San Francisco.
The boards of both companies have approved the deal, which should close in the fourth quarter of 2006. Avidia will be a wholly owned subsidiary of Amgen.
Published September 29, 2006 by San Francisco Business Times
Source: BizJournals.com
posted by Stock Administrator @ 3:25 PM
0 Comments:
Post a Comment
<< Home